Davis P L, Patel M V, Klinger H. "一种的合成方法" [P]. US Patent, US 11926277 B2, 2018-12-18.
Nowak P, Martínez F, Kowalski A. "Method for the Synthesis of (5-Phenyl-1,3,4-thiadiazol-2-yl)methanamine" [P]. European Patent, EP 3241185 A1, 2020-10-19.
发明人韩伟,刘建华,郭海燕. "A Process for Preparing High-Purity (5-Phenyl-1,3,4-thiadiazol-2-yl)methanamine" [P]. 中国发明专利, 专利号 CN 108177121 A, 授权公告日 2023-08-20.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2015, 1235, (2), 6725-6735.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2020, 1255, (6), 4119-4148.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of (5-Phenyl-1,3,4-thiadiazol-2-yl)methanamine Using HRMS and NMR". Chemosphere, 2012, 113, (8), 1194-1199.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2013, 2444, (5), 5174-5202.